open access

Vol 10, No 4 (2005)
Original Paper
Published online: 2005-01-01
Submitted: 2004-03-26
Get Citation

Prognostic index in lobular breast cancer

Mikołaj Musiał, Sylwia Grodecka-Gazdecka, Witold Kycler
DOI: 10.1016/S1507-1367(05)71089-0
·
Rep Pract Oncol Radiother 2005;10(4):165-172.

open access

Vol 10, No 4 (2005)
Original Paper
Published online: 2005-01-01
Submitted: 2004-03-26

Abstract

Background

The topic of this study was lobular carcinoma, the second most frequently diagnosed cancer of the breast, which is less well known and is more problematic, diagnostically.

Aim

To define a prognostic index for patients with lobular carcinoma of the breast through application of a multivariate analysis, Cox's proportional hazard model.

Materials/Methods

An immunohistochemistry based analysis was carried out on paraffin embedded materials taken from 75 women who underwent surgery for lobular carcinoma of the breast in the Oncological Surgery Department, Poznań University of Medical Sciences, during the period of 1990–1997.

Results

A statistically significant relationship was found between the size of tumour (p=0.044), lymph node status (p=0.011), expression of progesterone receptors (p=0.034), and survival time. In support of the above parameters, the multivariate analysis allowed the formulation of a prognostic index: I=T+2N-2PgR, where T (tumour)=tumour size, N (nodulus)=lymph node status, and PgR=expression of progesterone receptors.

Conclusions

The formulated prognostic index for lobular carcinoma of the breast allows for the differential prognosis of survival time, in representative risk groups. The index may be useful in the process of qualifying patients for adjuvant therapy.

Abstract

Background

The topic of this study was lobular carcinoma, the second most frequently diagnosed cancer of the breast, which is less well known and is more problematic, diagnostically.

Aim

To define a prognostic index for patients with lobular carcinoma of the breast through application of a multivariate analysis, Cox's proportional hazard model.

Materials/Methods

An immunohistochemistry based analysis was carried out on paraffin embedded materials taken from 75 women who underwent surgery for lobular carcinoma of the breast in the Oncological Surgery Department, Poznań University of Medical Sciences, during the period of 1990–1997.

Results

A statistically significant relationship was found between the size of tumour (p=0.044), lymph node status (p=0.011), expression of progesterone receptors (p=0.034), and survival time. In support of the above parameters, the multivariate analysis allowed the formulation of a prognostic index: I=T+2N-2PgR, where T (tumour)=tumour size, N (nodulus)=lymph node status, and PgR=expression of progesterone receptors.

Conclusions

The formulated prognostic index for lobular carcinoma of the breast allows for the differential prognosis of survival time, in representative risk groups. The index may be useful in the process of qualifying patients for adjuvant therapy.

Get Citation

Keywords

prognostic index; lobular carcinoma

About this article
Title

Prognostic index in lobular breast cancer

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 10, No 4 (2005)

Pages

165-172

Published online

2005-01-01

DOI

10.1016/S1507-1367(05)71089-0

Bibliographic record

Rep Pract Oncol Radiother 2005;10(4):165-172.

Keywords

prognostic index
lobular carcinoma

Authors

Mikołaj Musiał
Sylwia Grodecka-Gazdecka
Witold Kycler

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl